Home > Healthcare > Medical Devices > Therapeutic Devices > Pacemakers Market

Pacemakers Market Size

  • Report ID: GMI3776
  • Published Date: Jan 2024
  • Report Format: PDF

Pacemakers Market Size

Pacemakers Market size was valued at around USD 6.2 billion in 2023 and is anticipated to grow at a CAGR of around 10% between 2024 and 2032. The rising prevalence of cardiovascular diseases, surging incidence of arrhythmias, technological advancement, the growing ageing population, and supportive initiatives adopted by various governments & public organizations.

 

A pacemaker is a medical device that generates electrical impulses to regulate the heartbeat when the heart's natural electrical conduction system is not functioning properly, playing a critical role in cardiac rhythm management. Pacemakers help maintain an appropriate and consistent heart rate, ensuring that the heart beats regularly and at a sufficient rate to meet the body's oxygen and blood flow needs.

 

The high cost of these devices for patients not covered by insurance in the U.S. and patients in other parts of the world along with the cost of implantation procedures. The pacemaker device costs around USD 19,000 – 96,000 or more depending on the type of pacemaker, the location, and the length of stay. The total cost for pacemaker implantation ranges from USD 9,616 to 19,716 with an average cost of USD 14,290. The high cost of the device and procedures remains unaffordable to the low and middle-income patient population in the developing regions.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The pacemakers industry was valued at around USD 6.2 billion in 2023 and is estimated to reach over USD 9.2 billion by the end of 2032, owing to the rising prevalence of cardiovascular diseases and surging incidence of arrhythmias.

The dual-chamber pacemakers technology segment garnered around USD 4.8 billion in 2023 and is expected to foresee a healthy growth as increase in number of people suffering from atrioventricular block, who get benefited from using this device.

The U.S. pacemakers market is anticipated to expand at a notable pace to reach more than USD 3.1 billion by 2032, attributed to the presence of major industry players, an upsurge in the demand for cardiovascular devices, and the growing number of hospital admissions across the country.

Abbott Laboratories, Inc., Boston Scientific Corporation, Medtronic plc, BIOTRONIK SE & Co. KG, Lepu Medical Technology, Shree Pacetronix Ltd., Osypka Medical, MicroPort Scientific Corporation, Medico S.R.L., and Vitatron, among others.

Pacemakers Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 329
  • Countries covered: 22
  • Pages: 96
 Download Free Sample